111 Inc (YI)
1.00
+0.03
(+3.08%)
USD |
NASDAQ |
Apr 18, 16:00
111 Total Assets (Quarterly): 460.64M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 460.64M |
June 30, 2023 | 420.49M |
March 31, 2023 | 470.63M |
December 31, 2022 | 503.50M |
September 30, 2022 | 428.71M |
June 30, 2022 | 463.15M |
March 31, 2022 | 473.66M |
December 31, 2021 | 493.53M |
September 30, 2021 | 483.86M |
June 30, 2021 | 510.44M |
March 31, 2021 | 467.84M |
December 31, 2020 | 463.24M |
Date | Value |
---|---|
September 30, 2020 | 398.60M |
June 30, 2020 | 265.91M |
March 31, 2020 | 231.88M |
December 31, 2019 | 230.15M |
September 30, 2019 | 234.99M |
June 30, 2019 | 252.52M |
March 31, 2019 | 238.98M |
December 31, 2018 | 224.80M |
September 30, 2018 | 246.30M |
June 30, 2018 | 161.84M |
December 31, 2017 | 116.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
230.15M
Minimum
Dec 2019
510.44M
Maximum
Jun 2021
402.99M
Average
461.90M
Median
Total Assets (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | 836.81M |
Sinovac Biotech Ltd | 13.73B |
CASI Pharmaceuticals Inc | 75.27M |
Zai Lab Ltd | 1.036B |
I-MAB | 484.12M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 417.44M |
Shareholders Equity (Quarterly) | -70.35M |
Debt to Equity Ratio | -0.6806 |
Current Ratio | 1.072 |
Net Debt Paydown Yield | -0.85% |